The South Carolina Department of Commerce (S.C. Commerce) today announced the completion of final approvals for Octapharma’s first U.S. manufacturing and production facility in York County.
The $1.5 billion investment is projected to bring more than 1,500 jobs to Rock Hill, and marks a significant milestone as the biopharmaceutical manufacturer moves forward with establishing operations in South Carolina.
Headquartered in Lachen, Switzerland, Octapharma has more than 40 manufacturing and office sites worldwide, with production facilities in Austria, France, Germany and Sweden. The company, which was founded in 1983, develops and produces medicines based on proteins derived from human cell lines and human plasma.
This new facility will be located in Rock Hill’s Palmetto Research Park and include an administrative campus for Octapharma’s plasma donation operations.
Operations are expected to commence in the mid-2030s.
